Tokyo, Japan

Yusuke Sako


 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yusuke Sako: Innovator in Cyclic Peptide Synthesis

Introduction

Yusuke Sako is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of peptide synthesis, particularly in the development of novel cyclic peptide compounds. His innovative approach has the potential to advance various applications in pharmaceuticals and biotechnology.

Latest Patents

Yusuke Sako holds a patent for a process for synthesizing cyclic peptide compounds. The objective of this patent is to provide a novel method for synthesizing cyclic peptide compounds. The process involves two main steps: first, translationally synthesizing a non-cyclic peptide compound that contains a pair of functional groups capable of forming a bond. Second, the non-cyclic peptide compound is cyclized through the reaction of these functional groups to create a cyclic structure. This innovative process not only enhances the efficiency of synthesis but also contributes to the creation of novel cyclic peptide compounds.

Career Highlights

Yusuke Sako is affiliated with The University of Tokyo, where he conducts research and develops his innovative ideas. His work has garnered attention in the scientific community, showcasing his expertise in peptide chemistry and synthesis.

Collaborations

Yusuke Sako collaborates with notable researchers in his field, including Hiroaki Suga and Hiroshi Murakami. These collaborations enhance the scope of his research and contribute to the advancement of peptide synthesis techniques.

Conclusion

Yusuke Sako's contributions to the field of cyclic peptide synthesis exemplify the importance of innovation in scientific research. His patented process represents a significant advancement in the synthesis of cyclic compounds, paving the way for future developments in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…